Kathryn M. Ferguson

12.9k total citations · 6 hit papers
52 papers, 8.0k citations indexed

About

Kathryn M. Ferguson is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kathryn M. Ferguson has authored 52 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Oncology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kathryn M. Ferguson's work include Monoclonal and Polyclonal Antibodies Research (21 papers), HER2/EGFR in Cancer Research (20 papers) and Cellular transport and secretion (12 papers). Kathryn M. Ferguson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), HER2/EGFR in Cancer Research (20 papers) and Cellular transport and secretion (12 papers). Kathryn M. Ferguson collaborates with scholars based in United States, United Kingdom and Netherlands. Kathryn M. Ferguson's co-authors include Mark A. Lemmon, Joseph Schlessinger, Karl R. Schmitz, Shiqing Li, Daniel J. Leahy, Paul Kussie, Philip D. Jeffrey, J.J.W. Wiltzius, Paul B. Sigler and Mitchell B. Berger and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kathryn M. Ferguson

51 papers receiving 7.9k citations

Hit Papers

Structural basis for inhibition of the epidermal growth f... 1995 2026 2005 2015 2005 2003 2003 2000 1995 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
    2005 864 citations Shiqing Li, Karl R. Schmitz et al. Cancer Cell profile →
  2. An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
    2003 669 citations Kathryn M. Ferguson, Daniel J. Leahy et al. profile →
  3. EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization
    2003 588 citations Kathryn M. Ferguson, Daniel J. Leahy et al. profile →
  4. Signal-dependent membrane targeting by pleckstrin homology (PH) domains
    2000 583 citations Mark A. Lemmon, Kathryn M. Ferguson Biochemical Journal profile →
  5. Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain
    1995 504 citations Kathryn M. Ferguson, Mark A. Lemmon et al. Cell profile →
  6. The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
    2014 343 citations Mark A. Lemmon, Joseph Schlessinger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn M. Ferguson United States 34 5.4k 2.8k 2.2k 2.0k 909 52 8.0k
David F. Stern United States 64 7.6k 1.4× 5.8k 2.1× 2.9k 1.3× 1.5k 0.7× 801 0.9× 140 12.6k
Yosef Yarden Israel 11 4.5k 0.8× 4.5k 1.6× 2.4k 1.1× 535 0.3× 1.4k 1.5× 13 8.1k
Senthil K. Muthuswamy United States 46 6.3k 1.2× 4.4k 1.6× 827 0.4× 2.3k 1.1× 887 1.0× 91 9.7k
Henrik Daub Germany 35 5.4k 1.0× 1.7k 0.6× 562 0.3× 1.1k 0.6× 403 0.4× 56 7.6k
Joaquı́n Arribas Spain 47 4.6k 0.8× 5.0k 1.8× 2.4k 1.0× 722 0.4× 1.1k 1.3× 129 9.0k
Ivan Gout United Kingdom 52 9.7k 1.8× 1.7k 0.6× 978 0.4× 2.8k 1.4× 482 0.5× 157 12.8k
Sara Lavi Israel 38 4.4k 0.8× 3.2k 1.2× 1.6k 0.7× 583 0.3× 493 0.5× 72 6.7k
William J. Gullick United Kingdom 60 5.1k 0.9× 6.0k 2.2× 3.0k 1.3× 534 0.3× 1.3k 1.5× 154 10.3k
Abraham M. de Vos United States 48 6.8k 1.3× 2.6k 0.9× 2.2k 1.0× 691 0.3× 345 0.4× 65 10.9k
Byron Hann United States 39 3.9k 0.7× 2.5k 0.9× 696 0.3× 853 0.4× 646 0.7× 83 6.1k

Countries citing papers authored by Kathryn M. Ferguson

Since Specialization
Citations

This map shows the geographic impact of Kathryn M. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn M. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn M. Ferguson more than expected).

Fields of papers citing papers by Kathryn M. Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn M. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn M. Ferguson. The network helps show where Kathryn M. Ferguson may publish in the future.

Co-authorship network of co-authors of Kathryn M. Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn M. Ferguson. A scholar is included among the top collaborators of Kathryn M. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn M. Ferguson. Kathryn M. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagchi, Atrish, Steven E. Stayrook, Katerina T. Xenaki, et al.. (2024). Structural insights into the role and targeting of EGFRvIII. Structure. 32(9). 1367–1380.e6. 3 indexed citations
2.
Bradley, Judy, Kathryn M. Ferguson, Katherine O’Neill, et al.. (2022). Clinimetric Properties of Outcome Measures in Bronchiectasis. Annals of the American Thoracic Society. 20(5). 648–659. 2 indexed citations
3.
Hu, Chun, Anatoly Kiyatkin, Zhaolong Yu, et al.. (2022). Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias. Nature. 602(7897). 518–522. 53 indexed citations
4.
Lemmon, Mark A., et al.. (2018). Structural Basis for MARK1 Kinase Autoinhibition by Its KA1 Domain. Structure. 26(8). 1137–1143.e3. 15 indexed citations
5.
Bagchi, Atrish, Jaafar N. Haidar, Scott W. Eastman, et al.. (2017). Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance. Molecular Cancer Therapeutics. 17(2). 521–531. 46 indexed citations
6.
Lemmon, Mark A., et al.. (2016). Molecular determinants of KA1 domain-mediated autoinhibition and phospholipid activation of MARK1 kinase. Biochemical Journal. 474(3). 385–398. 19 indexed citations
7.
Bagchi, Atrish, Nicholas J. Bessman, Neo Wu, et al.. (2014). Allosteric Regulation of the Epidermal Growth Factor Receptor. Biophysical Journal. 106(2). 105a–105a. 1 indexed citations
8.
Wood, Christopher S., Karl R. Schmitz, Nicholas J. Bessman, et al.. (2009). PtdIns4 P recognition by Vps74/GOLPH3 links PtdIns 4-kinase signaling to retrograde Golgi trafficking. The Journal of Cell Biology. 187(7). 967–975. 139 indexed citations
9.
Schmitz, Karl R. & Kathryn M. Ferguson. (2008). Interaction of antibodies with ErbB receptor extracellular regions. Experimental Cell Research. 315(4). 659–670. 76 indexed citations
10.
Schmitz, Karl R., Jingxuan Liu, Shiqing Li, et al.. (2008). Golgi Localization of Glycosyltransferases Requires a Vps74p Oligomer. Developmental Cell. 14(4). 523–534. 157 indexed citations
11.
Schmitz, Karl R., et al.. (2008). Pellino Proteins Contain a Cryptic FHA Domain that Mediates Interaction with Phosphorylated IRAK1. Structure. 16(12). 1806–1816. 46 indexed citations
12.
Schmiedel, Judith, Andree Blaukat, Shiqing Li, Thorsten Knöchel, & Kathryn M. Ferguson. (2008). Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization. Cancer Cell. 13(4). 365–373. 125 indexed citations
13.
Bouyain, Samuel, Patti A. Longo, Shiqing Li, Kathryn M. Ferguson, & Daniel J. Leahy. (2005). The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proceedings of the National Academy of Sciences. 102(42). 15024–15029. 134 indexed citations
14.
Ferguson, Kathryn M.. (2003). Growth factors: can they promote neurogenesis?. Trends in Neurosciences. 26(6). 283–285. 18 indexed citations
15.
Lemmon, Mark A. & Kathryn M. Ferguson. (2001). Molecular determinants in pleckstrin homology domains that allow specific recognition of phosphoinositides. Biochemical Society Transactions. 29(4). 377–384. 86 indexed citations
16.
Ferguson, Kathryn M.. (2000). Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. The EMBO Journal. 19(17). 4632–4643. 119 indexed citations
17.
Lemmon, Mark A. & Kathryn M. Ferguson. (2000). Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochemical Journal. 350(1). 1–18. 583 indexed citations breakdown →
18.
Lemmon, Mark A., Kathryn M. Ferguson, & Joseph Schlessinger. (1996). PH Domains: Diverse Sequences with a Common Fold Recruit Signaling Molecules to the Cell Surface. Cell. 85(5). 621–624. 415 indexed citations
19.
Lemmon, Mark A., Kathryn M. Ferguson, & Joseph Schlessinger. (1996). PH Domains: Diverse Sequences with Minireview a Common Fold Recruit Signaling Molecules to the Cell Surface. 2 indexed citations
20.
Ferguson, Kathryn M., Mark A. Lemmon, Paul B. Sigler, & Joseph Schlessinger. (1995). Scratching the surface with the PH domain. Nature Structural & Molecular Biology. 2(9). 715–718. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David F. Stern Breakdown of academic impact, for papers by Yosef Yarden Breakdown of academic impact, for papers by Senthil K. Muthuswamy Breakdown of academic impact, for papers by Henrik Daub Breakdown of academic impact, for papers by Joaquı́n Arribas Breakdown of academic impact, for papers by Ivan Gout Breakdown of academic impact, for papers by Sara Lavi Breakdown of academic impact, for papers by William J. Gullick Breakdown of academic impact, for papers by Abraham M. de Vos Breakdown of academic impact, for papers by Byron Hann
Rankless by CCL
2026